Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, China - 20 Jun `26Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study

Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study

Official title: Efficacy and Safety of Ruxolitinib Phosphate Cream Combined With Corticosteroids in Patients With Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study

Status: Recruiting now

Description:

This study is a prospective, multicenter, real-world observational study to assess the clinical efficacy and safety of topical 1.5% Ruxolitinib phosphate cream used in combination with systemic corticosteroids in a real-world clinical setting. The study plans to observe patients aged 12 years and older with active, progressive non-segmental vitiligo involving the face. All treatments are prescribed based on standard routine clinical care and medical practice guidelines. Participants will apply Ruxolitinib cream twice daily to affected skin areas for up to 24 weeks alongside a standard corticosteroid regimen. The primary goal of the study is to evaluate how many patients achieve a 75% or greater improvement in their facial vitiligo patches after 12 weeks of combined treatment. Safety and side effects will also be closely monitored throughout the 24-week period.

What is being studied: drugs — 1.5% Ruxolitinib Phosphate Cream (Opzelura), Corticosteroid Therapy.

Who can take part: ages 12 Years, 300 participants planned.

Enrollment status: Open now. The study started 02 July 2026 and is expected to finish 31 December 2028.

Contact: ShanShan Li.

Source: ClinicalTrials.gov, NCT07673640 (https://clinicaltrials.gov/study/NCT07673640).

Start date: July 02, 2026

Completion date: December 31, 2028

Organizer: ShanShan Li

Contact: ShanShan Li

Tel.: +86 18201346463

Email: lishanshan@cms.net.cn

Link: https://clinicaltrials.gov/study/NCT07673640

Clinical Trial Alerts

Sign up and be the first to know about updates on this trial.

This request will be sent with the trial reference Ruxolitinib Cream Combined With Corticosteroids for Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study . By submitting you agree to our Privacy Policy.

FAQOther Questions

  • Do Antioxidant Supplements Help Vitiligo?

    Do Antioxidant Supplements Help Vitiligo? Short answer Maybe a little. But probably not in the way most people hope. Antioxidant supplements may offer modest support, especially...

  • Awareness Days Similar to World Vitiligo Day

    World Vitiligo Day, celebrated annually on June 25 since 2012, is a significant event dedicated to raising awareness about vitiligo and supporting those affected by the conditio...

  • How smoking affects vitiligo?

    Smoking is a common habit linked to numerous health risks, affecting multiple body systems and increasing various disease risks, including respiratory and cardiovascular issues....